Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Share-based Compensation (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Share-based Compensation for 5 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 50.8% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $9.0 million, down 31.11%, while the annual FY2025 figure was $9.0 million, 31.11% down from the prior year.
  • Share-based Compensation hit $1.6 million in Q4 2025 for Kezar Life Sciences, down from $2.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $6.6 million in Q3 2023 and bottomed at $1.6 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $3.1 million, with a median of $3.1 million recorded in 2022.
  • Year-over-year, Share-based Compensation surged 105.99% in 2022 and then tumbled 51.99% in 2024.
  • Kezar Life Sciences' Share-based Compensation stood at $1.9 million in 2021, then soared by 105.99% to $3.8 million in 2022, then fell by 15.64% to $3.2 million in 2023, then increased by 2.7% to $3.3 million in 2024, then tumbled by 50.8% to $1.6 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $1.6 million, $2.1 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.